Pancreatic Cancer Research

Digest Map Explore About

Open data from ClinicalTrials.gov, Europe PMC, NIH RePORTER and OpenAlexFor research and education, not medical adviceAbout this project

The Pancreatic Cancer Research Digest

New trials, papers and changes to existing records, compiled daily from the public registries

Friday, September 4, 202610 items · 0 changes to existing records

← Previous day Next day →

New paper

Targeting Reactive Species Stress and Nutrient Sensing to Enhance NK-Cell Function: Mechanistic Strategies for Overcoming Pancreatic Cancer Progression and Resistance Through Supplement Therapy.

Why it was picked newest record on or before this date

DOI 10.3390/ijms27177893 ↗ Sep 4, 2026

In this edition

New trials: 0
New papers: 10
New grants: 0
Other new records: 0
Status changes: 0
Results posted: 0
Retractions: 0
Other updates: 0

New paper

Deaths Mentioning Both Pancreatic Cancer and Renal Failure in the United States, 1999-2024: Temporal Trends and Disparities.

Why it was picked newest record on or before this date

DOI 10.3390/epidemiologia7050124 ↗ Sep 4, 2026

New paper

Integrated analysis of isorhamnetin-associated targets in chronic pancreatitis and pancreatic cancer: immune-infiltration associations and antitumor effects in pancreatic cancer cells.

Why it was picked newest record on or before this date

DOI 10.3389/fimmu.2026.1902080 ↗ Sep 4, 2026

New paper

Association between adherence to the Mediterranean Diet and pancreatic cancer risk: a systematic review and meta-analysis.

Why it was picked newest record on or before this date

DOI 10.3389/fnut.2026.1925019 ↗ Sep 4, 2026

New paper

Adjuvant FOLFIRINOX versus S-1 monotherapy for resected PDAC: retrospective real-world data.

Why it was picked newest record on or before this date

DOI 10.1177/17588359261470681 ↗ Sep 4, 2026

Also today

New paper

Activation of PP2A-B56a leads to aberrant EGFR signaling and proliferative phenotypes in PDAC.

DOI 10.1158/1535-7163.mct-25-0970 ↗ Sep 4, 2026

New paper

Chemotherapy Reawakens Dormant Disseminated Pancreatic Cancer Cells in the Liver by Promoting Senescent Hepatocyte-Induced Neutrophil Extracellular Traps.

DOI 10.1158/0008-5472.can-26-0151 ↗ Sep 4, 2026

New paper

Synthetic long peptide and DNA personalized cancer vaccines induce robust neoantigen-specific T cell responses in pancreatic cancer.

DOI 10.1126/sciadv.aei1190 ↗ Sep 4, 2026

New paper

Exploring patient perspectives of exercise in advanced pancreatic cancer care in Canada: A qualitative interpretive description.

What changed

Change tracking began 4 November 2026, after this day, so only its new records are listed.

Compiled by the knowledge layer from its change log. Every headline opens the underlying record; every identifier links to its source.

DOI 10.1017/s1478951526103356

·

Sep 4, 2026

New paper

Intraoperative decision-making for pancreatic ductal adenocarcinoma with occult para-aortic lymph node metastasis: Proposal of a pathology-based weighted risk scoring system.

DOI 10.1016/j.suronc.2026.102559 ↗ Sep 4, 2026